IP strategies
Pharma IQ’s IP Strategies for Crystalline Forms Report
August 04 by Pharma IQ NewsPharma IQ has just published the results of an industry wide IP Crystals Survey, conducted recently among 6,000 patent specialists with over 65 % of those surveyed directly responsible for app...
Europe Remains Most Important for Patent Strategies for 83.3% of Pharma Firms
August 01 by Pharma IQRight across the global pharmaceutical industry, companies are desperately seeking to diversify their product portfolios in anticipation of the countless patent expiries to follow those already seen...
How to Address the IP Issues Specifically Associated with Polymorphic Forms
September 28 by Pharma IQIt is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutica...
